Feature Review Papers in Cardiac Surgery

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Cardiac Surgery".

Deadline for manuscript submissions: closed (15 January 2024) | Viewed by 2671

Special Issue Editors

1. Department of Cardiac Surgery, National and Kapodistrian University of Athens, 11528 Athens, Greece
2. Department of Cardiac Surgery, Mouwasat Hospital Dammam, Dammam 32263, Saudi Arabia
Interests: cardiac surgery; coronary artery bypass grafting; heart valve surgery; thoracic aortic aneurysm; risk stratification; predictive models; in-hospital outcome; long-term outcome; postoperative complications; spinal cord ischemia; ischemic preconditioning; molecular biology of aortic aneurysms; general thoracic surgery; molecular biology of lung cancer; experimental models of aortic aneurysms
Special Issues, Collections and Topics in MDPI journals
Cardiac Surgery Department, Cardiocentro Ticino Institute, Via Tesserete 48, CH-6900 Lugano, Switzerland
Interests: transcatheter heart valve procedures; minimally invasive cardiac surgery; myocardial protection; development of new transcatheter technologies; transcatheter aortic root replacement (TARR) procedures
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cardiac surgery represents one of the leading specialties undergoing continuous improvement and providing many opportunities for enhancements aiming at favorable outcomes. The development of new techniques which are non-invasive or less invasive, as well as the refinement of established procedures have led to significant progress in the last decade. Novel predictive models for risk stratification have contributed significantly to clinical decision making. Meticulous preoperative assessment as well as intraoperative and postoperative monitoring have provided the best practices and contributed to decreasing numbers of complications and mortality, while effectively improving patients’ quality of life. The purpose of this Special Issue entitled “Feature Review Papers in Cardiac Surgery” is to summarize the latest advances in cardiac surgery through a series of review papers. These topics involve not only cardiac surgeons, but also closely related specialties, which are of paramount importance for the quality improvement of clinical outcomes (cardiology, cardiac anesthesia, intensive care etc.). All cardiac surgeons are required to keep up to date with current best practices and new advances as part of their continuous education, and this Special Issue aims to be an important reference for this purpose.

Dr. Ioannis K. Toumpoulis
Prof. Dr. Enrico Ferrari
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiac surgical procedures education, methods, trends, and quality improvement
  • surgical performance
  • cardiovascular diseases
  • surgery
  • minimally invasive surgery
  • coronary artery disease
  • complications of ischemic heart disease
  • coronary artery bypass grafting
  • redo coronary artery bypass grafting
  • combined coronary artery bypass grafting
  • bilateral internal thoracic artery
  • thoracic aortic aneurysm
  • heart valve disease
  • aortic valve disease
  • mitral valve disease
  • tricuspid valve disease
  • heart valve repair
  • heart valve prosthesis
  • risk factors
  • comorbidities
  • in-hospital outcome
  • long-term outcome
  • postoperative complications
  • mortality
  • long-term survival
  • predictive model
  • risk stratification algorithm
  • heart transplantation
  • heart failure
  • ventricular assist devices
  • cardiac anesthesia
  • postoperative monitoring
  • surgery for arrhythmia
  • experimental models
  • neurologic complications
  • endovascular prosthesis
  • heart team
  • biomarkers
  • gene expression
  • genomics
  • proteomics
  • medical therapy
  • pharmaceutical interventions
  • anti-coagulation
  • extracorporeal membrane oxygenation
  • intra-aortic balloon pump
  • Impella heart pump
  • clinical trials
  • infection
  • diagnosis
  • prognosis
  • treatment
  • adult congenital cardiac disease
  • pulmonary embolism
  • hypertrophic cardiomyopathy
  • tumors of the heart
  • trauma of the heart

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 1377 KiB  
Review
Transcatheter Aortic Valve Implantation Access Sites: Same Goals, Distinct Aspects, Various Merits and Demerits
J. Cardiovasc. Dev. Dis. 2024, 11(1), 4; https://doi.org/10.3390/jcdd11010004 - 22 Dec 2023
Viewed by 959
Abstract
Transcatheter aortic valve implantation (TAVI) has been established as a safe and efficacious treatment for patients with severe symptomatic aortic stenosis (AS). Despite being initially developed and indicated for high-surgical-risk patients, it is now offered to low-risk populations based on the results of [...] Read more.
Transcatheter aortic valve implantation (TAVI) has been established as a safe and efficacious treatment for patients with severe symptomatic aortic stenosis (AS). Despite being initially developed and indicated for high-surgical-risk patients, it is now offered to low-risk populations based on the results of large randomized controlled trials. The most common access sites in the vast majority of patients undergoing TAVI are the common femoral arteries; however, 10–20% of the patients treated with TAVI require an alternative access route, mainly due to peripheral atherosclerotic disease or complex anatomy. Hence, to achieve successful delivery and implantation of the valve, several arterial approaches have been studied, including transcarotid (TCr), axillary/subclavian (A/Sc), transapical (TAp), transaortic (TAo), suprasternal-brachiocephalic (S-B), and transcaval (TCv). This review aims to concisely summarize the most recent literature data and current guidelines as well as evaluate the various access routes for TAVI, focusing on the indications, the various special patient groups, and the advantages and disadvantages of each technique, as well as their adverse events. Full article
(This article belongs to the Special Issue Feature Review Papers in Cardiac Surgery)
Show Figures

Figure 1

9 pages, 858 KiB  
Review
The VEST External Support for Saphenous Vein Grafts in Coronary Surgery: A Review of Randomized Clinical Trials
J. Cardiovasc. Dev. Dis. 2023, 10(11), 453; https://doi.org/10.3390/jcdd10110453 - 07 Nov 2023
Viewed by 1293
Abstract
Saphenous vein grafts (SVGs) are the most frequently used conduits in coronary artery bypass grafting (CABG), but their higher rate of occlusion compared to arterial conduits remains a concern. Previous studies have shown that SVG failure is mainly driven by intimal hyperplasia, an [...] Read more.
Saphenous vein grafts (SVGs) are the most frequently used conduits in coronary artery bypass grafting (CABG), but their higher rate of occlusion compared to arterial conduits remains a concern. Previous studies have shown that SVG failure is mainly driven by intimal hyperplasia, an adaptative response to higher pressures of the arterial circulation. The VESTTM device (Vascular Graft Solutions, Tel Aviv, Israel), an external support designed to mitigate intimal hyperplasia in SVGs, has been tested in few clinical trials (RCTs). Herein, we descriptively evaluated the randomized evidence on the VEST device. Full article
(This article belongs to the Special Issue Feature Review Papers in Cardiac Surgery)
Show Figures

Figure 1

Back to TopTop